News
-
-
PRESS RELEASE
CGTN AMERICA & CCTV UN: CMG Presents "Prelude to the Spring Festival Gala" in New York City, Celebrating the Year of the Horse
CGTN America & CCTV UN presents 'Prelude to the Spring Festival Gala' in New York City celebrating the Year of the Horse, showcasing cultural celebration, innovation, and global unity -
PRESS RELEASE
SAUDI ARABIA ANNOUNCES 2026 FUTURE AVIATION FORUM TO CONVENE GLOBAL AVIATION LEADERS, EXTENDS RECORD-BREAKING AVIATION GROWTH
Saudi Arabia announces the 2026 Future Aviation Forum in Riyadh to gather global aviation leaders, highlighting record-breaking aviation growth. Registration open now -
PRESS RELEASE
Verdera Energy Closes $20 Million Financing and Provides Update to Proposed Qualifying Transaction and Listing on the TSX-V
Verdera Energy Corp. and POCML 7 Inc. announce the closing of their $20 million offering. Verdera to trade on TSX-V under ticker symbol 'V'. Proceeds for project advancement and working capital -
PRESS RELEASE
iGarden and French National Swimming Association Announce Exclusive Strategic Partnership and Reveal French Market Roadmap
iGarden and French National Swimming Association announce exclusive strategic partnership, unveiling French market roadmap at special event with French Olympic legends Alain Bernard and Fabien Gilot -
-
PRESS RELEASE
GENFIT to receive US$20M milestone after Ipsen’s Iqirvo® exceeds the US$200M threshold in its first full year of net sales
GENFIT receives US$20M milestone from Ipsen as Iqirvo® surpasses US$200M net sales threshold in 2025. Phase 3 in PSC confirmed. CCA Phase 1b study progressing as planned. Financial position reinforced -
PRESS RELEASE
GENFIT va recevoir un paiement d’étape de 20 M$ suite au dépassement du seuil des 200 M$ de ventes nettes d’Iqirvo® par Ipsen dès sa première année complète de commercialisation
GENFIT recevra un paiement d'étape de 20 M$ suite au dépassement des ventes nettes d'Iqirvo® par Ipsen, confirmant le lancement d'une Phase 3 dans la PSC et les progrès de l'étude de Phase 1b dans le CCA -
PRESS RELEASE
Croissance organique de +8,2% au 1er semestre 2025-2026 : Confirmation d'une belle dynamique dans les Prestations de santé à domicile : +9,2% ; Accélération de la croissance dans le Maintien à domicile à +6,5%. Objectifs 2025-2026 confirmés
Le Groupe Bastide annonce un chiffre d'affaires en hausse de 8,0% au 1er semestre 2025-2026, atteignant 260,4 M€. Croissance portée par les activités de santé à domicile et maintien à domicile -
PRESS RELEASE
Organic growth of 8.2% in first-half 2025-2026: Confirmed excellent growth momentum in home healthcare services: 9.2% / Accelerated growth in the Homecare business, up 6.5% // 2025-2026 targets confirmed
Groupe Bastide reports 8.0% revenue growth in first-half 2025-2026, reaching €260.4 million. Strong performance driven by Homecare and Respiratory businesses. Outlook confirms annual revenue target of €510 million
